Understanding the Role of Metabolic Syndrome as a Risk Factor for Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) and metabolic syndrome (MetS) have a rising prevalence worldwide. The relationship between these two entities has long been studied and understanding it has become a public health and clinical priority. This association follows, in most patients, the path through non-a...

Descripción completa

Detalles Bibliográficos
Autores principales: Chavez-Tapia, Norberto C, Murúa-Beltrán Gall, Sofía, Ordoñez-Vázquez, Ana Luisa, Nuño-Lambarri, Natalia, Vidal-Cevallos, Paulina, Uribe, Misael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270896/
https://www.ncbi.nlm.nih.gov/pubmed/35818404
http://dx.doi.org/10.2147/JHC.S283840

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270896/
https://www.ncbi.nlm.nih.gov/pubmed/35818404
http://dx.doi.org/10.2147/JHC.S283840

Ejemplares similares